Tag Archives: EML4-ALK

THOROLD, ON, March 2, 2016 /CNW/ – Norgen Biotek Corp., an innovative Canadian biotechnology company focusing on advancing powerful tools for DNA, RNA and protein stabilization and purification, today announced the signing of a supplier agreement with Biodesix, Inc. to ...

ExoDx Lung(ALK) is the World’s First Non-invasive Test Allowing Identification of Specific ALK Fusions Using Exosomal RNA-Based Liquid Biopsy ExoDx Lung(ALK) is the First in a Series of Exosomal RNA-based Liquid Biopsies across Multiple Bio-fluids and Solid Tumors Expected to ...

In the study, the Exosome Diagnostics EML4-ALK assay detected all EML4-ALK fusion transcripts based on the presence of the ALK kinase domain; importantly for therapy selection, the assay was able to differentiate between the three major known fusion transcript variants, ...